Ethinyl Estradiol; Levonorgestrel Patent Expiration
Ethinyl Estradiol; Levonorgestrel is Used for preventing pregnancy in women using oral contraceptives. It was first introduced by Teva Branded Pharmaceutical Products R And D Inc
Ethinyl Estradiol; Levonorgestrel Patents
Given below is the list of patents protecting Ethinyl Estradiol; Levonorgestrel, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Balcoltra | US6716814 | Enhancing solubility of iron amino acid chelates and iron proteinates |
Aug 16, 2021
(Expired) | Avion Pharms |
| Balcoltra | US7838042 | Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions | Jun 01, 2027 | Avion Pharms |
| Loseasonique | US7615545 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Jun 15, 2023
(Expired) | Teva Branded Pharm |
| Loseasonique | US7855190 | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | Dec 05, 2028 | Teva Branded Pharm |
| Loseasonique | US7858605 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Jun 23, 2023
(Expired) | Teva Branded Pharm |
| Lybrel | US6500814 | Hormonal contraceptive |
Sep 03, 2018
(Expired) | Wyeth Pharms Inc |
| Preven Emergency Contraceptive Kit | US6156742 | Emergency contraceptive kit |
Dec 05, 2020
(Expired) | Teva Branded Pharm |
| Quartette | US8415332 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | Mar 11, 2029 | Teva Branded Pharm |
| Quartette | US8450299 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | Oct 07, 2025 | Teva Branded Pharm |
| Seasonale | US5898032 | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
Jun 23, 2017
(Expired) | Teva Branded Pharm |
| Seasonale | USRE39861 | Methods of extended use oral contraception |
Jun 23, 2017
(Expired) | Teva Branded Pharm |
| Seasonique | US7320969 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Jan 30, 2024
(Expired) | Teva Branded Pharm |
| Seasonique | US7615545 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Jun 15, 2023
(Expired) | Teva Branded Pharm |
| Seasonique | US7855190 | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | Dec 05, 2028 | Teva Branded Pharm |
| Seasonique | US7858605 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Jun 23, 2023
(Expired) | Teva Branded Pharm |
| Twirla | US7045145 | Transdermal contraceptive delivery system and process |
Mar 14, 2021
(Expired) | Agile |
| Twirla | US7384650 | Skin permeation enhancement composition for transdermal hormone delivery system |
Mar 14, 2021
(Expired) | Agile |
| Twirla | US8221784 | Transdermal hormone delivery system: compositions and methods |
Mar 14, 2021
(Expired) | Agile |
| Twirla | US8221785 | Transdermal hormone delivery system: compositions and methods |
Mar 14, 2021
(Expired) | Agile |
| Twirla | US8246978 | Dermal delivery device with reduced loss of its volatile components | Aug 26, 2028 | Agile |
| Twirla | US8747888 | Dermal delivery device with in situ seal | Jul 10, 2028 | Agile |
| Twirla | US8883196 | Transdermal hormone delivery system: compositions and methods |
Nov 22, 2020
(Expired) | Agile |
| Twirla | US9050348 | Dermal delivery device | Jul 10, 2028 | Agile |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ethinyl Estradiol; Levonorgestrel's patents.
Latest Legal Activities on Ethinyl Estradiol; Levonorgestrel's Patents
Given below is the list recent legal activities going on the following patents of Ethinyl Estradiol; Levonorgestrel.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed | 04 Mar, 2024 | US8221785 |
| Maintenance Fee Reminder Mailed | 04 Mar, 2024 | US8221784 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 21 Feb, 2024 | US8246978 |
| Expire Patent | 19 Dec, 2022 | US8883196 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 09 Dec, 2022 | US9050348 |
| Maintenance Fee Reminder Mailed | 04 Jul, 2022 | US8883196 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Nov, 2020 | US8450299(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Oct, 2020 | US8415332(Litigated) |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Feb, 2020 | US8246978 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 17 Jan, 2020 | US8221784 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Ethinyl Estradiol; Levonorgestrel Generics
Several generic applications have been filed for Ethinyl Estradiol; Levonorgestrel. The first generic version for Ethinyl Estradiol; Levonorgestrel was by Watson Laboratories Inc and was approved on Dec 13, 1993. And the latest generic version is by Lupin Ltd and was approved on Feb 15, 2024.
Given below is the list of companies who have filed for Ethinyl Estradiol; Levonorgestrel generic.
1. HETERO LABS
Hetero Labs Ltd has filed for 1 generic for Ethinyl Estradiol; Levonorgestrel. This 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Hetero Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Prescription | ORAL-28 | AB1 | Feb 13, 2023 |
2. WATSON LABS
Watson Laboratories Inc has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name QUASENSE, 0.02mg;0.09mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Sep 6, 2006 |
| 0.02MG; 0.09MG
(reference standard) | tablet | Prescription | ORAL | AB | Jun 6, 2011 |
3. XIROMED
Xiromed Pharma Espana Sl has filed for 6 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, 0.03mg,0.01mg;0.15mg,n/a version comes by the name JAIMIESS, 0.02mg,0.1mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg,0.15mg;0.025mg,0.15mg;0.03mg,0.15mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Xiromed.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Apr 21, 2015 |
| 0.02MG; 0.1MG | tablet | Prescription | ORAL | AB3 | Aug 16, 2023 |
| 0.03MG,0.01MG; 0.15MG,N/A | tablet | Prescription | ORAL | AB | Dec 27, 2017 |
| 0.02MG,0.1MG; 0.01MG,N/A | tablet | Prescription | ORAL | AB | Dec 14, 2017 |
| 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG | tablet | Discontinued | ORAL-28 | N/A | Mar 23, 2018 |
| 0.02MG,0.15MG; 0.025MG,0.15MG; 0.03MG,0.15MG; 0.01MG,N/A | tablet | Prescription | ORAL | AB | Oct 2, 2017 |
4. LUPIN LTD
Lupin Ltd has filed for 6 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg,0.1mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, 0.03mg;0.15mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg;0.1mg version comes by the name MINZOYA, 0.03mg,0.01mg;0.15mg,n/a version comes by the name DAYSEE, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg,0.15mg;0.025mg,0.15mg;0.03mg,0.15mg;0.01mg,n/a version comes by the name FAYOSIM. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG,0.1MG; 0.01MG,N/A | tablet | Prescription | ORAL | AB | Oct 26, 2011 |
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Oct 23, 2012 |
| 0.02MG; 0.1MG | tablet | Prescription | ORAL | AB3 | Feb 15, 2024 |
| 0.03MG,0.01MG; 0.15MG,N/A | tablet | Prescription | ORAL | AB | Apr 10, 2013 |
| 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG | tablet | Prescription | ORAL-28 | AB | Nov 19, 2015 |
| 0.02MG,0.15MG; 0.025MG,0.15MG; 0.03MG,0.15MG; 0.01MG,N/A | tablet | Discontinued | ORAL | N/A | Mar 29, 2016 |
5. BARR
Barr Laboratories Inc has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.03mg;0.15mg version comes by the name PORTIA-21. Given below are the details of the strengths of this generic introduced by Barr.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Discontinued | ORAL-21 | N/A | Apr 29, 2003 |
| 0.03MG; 0.15MG | tablet | Discontinued | ORAL-21 | N/A | May 23, 2002 |
6. DURAMED PHARMS BARR
Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name AVIANE-28, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name ENPRESSE-28. Given below are the details of the strengths of this generic introduced by Duramed Pharms Barr.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Prescription | ORAL-28 | AB1 | Apr 30, 2001 |
| 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG | tablet | Prescription | ORAL-28 | AB | Jul 16, 2001 |
7. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.03mg,0.01mg;0.15mg,n/a version comes by the name ASHLYNA, 0.02mg;0.09mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Jun 12, 2015 |
| 0.03MG,0.01MG; 0.15MG,N/A | tablet | Prescription | ORAL | AB | Feb 23, 2015 |
| 0.02MG; 0.09MG | tablet | Prescription | ORAL | AB | Apr 9, 2015 |
8. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Ethinyl Estradiol; Levonorgestrel. This 0.03mg;0.15mg version comes by the name ICLEVIA. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Jun 29, 2018 |
9. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. All of these versions come by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Discontinued | ORAL-28 | N/A | Feb 5, 2014 |
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Nov 13, 2015 |
| 0.03MG,0.01MG; 0.15MG,N/A | tablet | Prescription | ORAL | AB | Dec 22, 2015 |
10. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name CERINTA, 0.03mg;0.15mg version comes by the name SYLEVIA. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Discontinued | ORAL-28 | N/A | Jan 7, 2019 |
| 0.03MG; 0.15MG | tablet | Discontinued | ORAL | N/A | Feb 6, 2019 |
11. NAARI PTE LTD
Naari Pte Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. All of these versions come by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Naari Pte Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Prescription | ORAL-28 | AB1 | Aug 17, 2020 |
| 0.03MG; 0.15MG | tablet | Prescription | ORAL-28 | AB | Oct 9, 2020 |
12. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name ORSYTHIA, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name MYZILRA. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG; 0.1MG | tablet | Discontinued | ORAL-28 | N/A | May 11, 2011 |
| 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG | tablet | Prescription | ORAL-28 | AB | Nov 23, 2011 |
13. NOVAST LABS
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name SETLAKIN, 0.02mg;0.09mg version comes by the name DOLISHALE. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG | tablet | Prescription | ORAL | AB | Sep 15, 2014 |
| 0.02MG; 0.09MG | tablet | Prescription | ORAL | AB | Oct 22, 2020 |
14. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name AYUNA, 0.02mg;0.1mg version comes by the name AFIRMELLE, 0.03mg,0.01mg;0.15mg,n/a version comes by the name SIMPESSE, 0.02mg,0.1mg;0.01mg,n/a version comes by the name LO SIMPESSE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG | tablet | Prescription | ORAL-28 | AB | Sep 23, 2016 |
| 0.02MG; 0.1MG | tablet | Prescription | ORAL-28 | AB1 | Nov 14, 2016 |
| 0.03MG,0.01MG; 0.15MG,N/A | tablet | Prescription | ORAL | AB | Apr 7, 2017 |
| 0.02MG,0.1MG; 0.01MG,N/A | tablet | Prescription | ORAL | AB | Apr 28, 2017 |
15. NOVAST LABS LTD
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name LEVONEST, 0.02mg;0.1mg version comes by the name FALMINA. Given below are the details of the strengths of this generic introduced by Novast Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG | tablet | Prescription | ORAL-28 | AB | Dec 29, 2010 |
| 0.02MG; 0.1MG | tablet | Prescription | ORAL-28 | AB1 | Mar 28, 2012 |
16. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 5 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name LEVORA 0.15/30-28, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name TRIVORA-21, 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.03mg,0.01mg;0.15mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, 0.02mg,0.1mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.03MG; 0.15MG
(reference standard) | tablet | Prescription | ORAL-28 | AB | Dec 13, 1993 |
| 0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG | tablet | Discontinued | ORAL-21 | N/A | Dec 18, 1997 |
| 0.02MG; 0.1MG
(reference standard) | tablet | Prescription | ORAL-28 | AB2 | May 31, 2006 |
| 0.03MG,0.01MG; 0.15MG,N/A | tablet | Prescription | ORAL | AB | May 31, 2011 |
| 0.02MG,0.1MG; 0.01MG,N/A | tablet | Discontinued | ORAL | N/A | Oct 25, 2011 |